ARCHIVES

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

This article is from The Cancer Letter archive.

Vol. 24 No. 03 | January 23, 1998

Download PDF Visit The Full Archive

Related Articles

Year 2000 Objectives In Health On Track

June 25, 1999

NCI, Rhone-Poulenc Sign Agreement For Taxotere Trials

June 19, 1992

CCOP Review Completed; 72 Applications Submitted, 23 More For Minority CCOP

December 1, 1989

Facing Congressional Criticism, NIH Starts Review of Extramural Conflict Policies.

June 13, 2008

NCI Promises Strong Monitoring Process Visco Calls For Independent Review; Rep. Dingell Plans Hearing April 13

April 1, 1994

Cancer Program Advocates, Success Overcame Powerful Negative Factors To Win Budget Fight

August 10, 1979